Nucleic acid delivery to specific tissues and cells is very challenging. To address the delivery barriers, a variety of nanoparticle formulations, including lipid nanoparticles, have been tested. In this presentation, we will focus with case studies on endogenous mechanisms that can enhance nucleic acid delivery to their target – especially extrahepatic delivery.

Three strategies - role of protein corona, use of cells as Trojan Horse, and extracellular vesicles – will be discussed.

In this webinar you’ll learn:

1. Ascendia’s expertise and capabilities in NPs
2. Role of protein corona on tissue and cell-specific targeting
3. Peritoneal macrophage tropism to disease sites
4. Extracellular vesicle-mediated in vivo delivery

Who should attend:

• Industrial Pharmaceutical Scientists- (Manager, VP, CSO, CTO)
• Academic Pharmaceutical Scientists – (MS/PhD Students, Postdocs)
• Consultants